特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
959307

結核検査の世界市場

Tuberculosis Testing

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 294 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.41円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

結核検査の世界市場
出版日: 2020年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 294 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の結核検査の市場規模は、分析期間(2020年~2027年)に2.5%のCAGRで成長する見通しで、2020年の24億米ドルから2027年には28億米ドルに達すると予測されています。当レポートで分析されているセグメントの1つである胸部X線は、分析期間中に3%の年率で成長し、6億2,850万米ドルに達すると予測されています。

当レポートは、世界の結核検査市場について調査しており、市場シェア、動向や見通し、成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

調査対象企業の例

  • Abbott Laboratories, Inc.
  • Akonni Biosystems, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Cepheid, Inc.
  • Creative Diagnostics
  • Danaher Corporation
  • Epistem Ltd.
  • F. Hoffmann-La Roche AG
  • Hain Lifescience GmbH
  • Hologic, Inc.
  • Lionex GmbH
  • Oxford Immunotec Ltd.
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

目次

I. イントロダクション、調査手法、調査範囲

II. エグゼクティブサマリー

  • 市場概要
    • 競合の市場シェア
    • 競合の市場シェアシナリオ
    • Covid-19の影響と迫り来る世界の景気後退
  • 主要企業
  • 動向と成長要因
  • 世界市場の見通し

III. 市場分析

  • 地域別市場分析
  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋
  • 中南米
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

IV. 競合

  • プロファイルされた企業の総数:42社
目次
Product Code: MCP16869

Global Tuberculosis Testing Market to Reach $2.8 Billion by 2027

Amid the COVID-19 crisis, the global market for Tuberculosis Testing estimated at US$2.4 Billion in the year 2020, is projected to reach a revised size of US$2.8 Billion by 2027, growing at a CAGR of 2.5% over the analysis period 2020-2027. Chest X-Ray, one of the segments analyzed in the report, is projected to record a 3% CAGR and reach US$628.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Culture Based Tests segment is readjusted to a revised 2.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $642.2 Million, While China is Forecast to Grow at 4.6% CAGR

The Tuberculosis Testing market in the U.S. is estimated at US$642.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$564.5 Million by the year 2027 trailing a CAGR of 4.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.6% and 1.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.1% CAGR.

IGRA (Interferon-Gamma Release Assays) Segment to Record 3.1% CAGR

In the global IGRA (Interferon-Gamma Release Assays) segment, USA, Canada, Japan, China and Europe will drive the 2.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$286.8 Million in the year 2020 will reach a projected size of US$343.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$385.8 Million by the year 2027, while Latin America will expand at a 4% CAGR through the analysis period. We bring years of research experience to this 8th edition of our report. The 294-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Laboratories, Inc.
  • Akonni Biosystems, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Cepheid, Inc.
  • Creative Diagnostics
  • Danaher Corporation
  • Epistem Ltd.
  • F. Hoffmann-La Roche AG
  • Hain Lifescience GmbH
  • Hologic, Inc.
  • Lionex GmbH
  • Oxford Immunotec Ltd.
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Tuberculosis Testing Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Tuberculosis Testing Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 2: Tuberculosis Testing Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
    • TABLE 3: Tuberculosis Testing Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
    • TABLE 4: Chest X-Ray (Test Type) World Market by Region/Country in US$ Million: 2020 to 2027
    • TABLE 5: Chest X-Ray (Test Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
    • TABLE 6: Chest X-Ray (Test Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 7: Culture Based Tests (Test Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
    • TABLE 8: Culture Based Tests (Test Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
    • TABLE 9: Culture Based Tests (Test Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
    • TABLE 10: IGRA (Interferon-Gamma Release Assays) (Test Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
    • TABLE 11: IGRA (Interferon-Gamma Release Assays) (Test Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
    • TABLE 12: IGRA (Interferon-Gamma Release Assays) (Test Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 13: Nucleic Acid Testing (NAT) (Test Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
    • TABLE 14: Nucleic Acid Testing (NAT) (Test Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
    • TABLE 15: Nucleic Acid Testing (NAT) (Test Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 16: Smear Microscopy (Test Type) World Market by Region/Country in US$ Million: 2020 to 2027
    • TABLE 17: Smear Microscopy (Test Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
    • TABLE 18: Smear Microscopy (Test Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 19: Serological Tests (Test Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
    • TABLE 20: Serological Tests (Test Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to 2019
    • TABLE 21: Serological Tests (Test Type) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 22: Other Test Types (Test Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027
    • TABLE 23: Other Test Types (Test Type) Global Historic Demand in US$ Million by Region/Country: 2012 to 2019
    • TABLE 24: Other Test Types (Test Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 25: Academics & Research (End-Use) Worldwide Sales in US$ Million by Region/Country: 2020-2027
    • TABLE 26: Academics & Research (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
    • TABLE 27: Academics & Research (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
    • TABLE 28: Hospitals Laboratories (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 29: Hospitals Laboratories (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019
    • TABLE 30: Hospitals Laboratories (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 31: Physicians Office Laboratories (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027
    • TABLE 32: Physicians Office Laboratories (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
    • TABLE 33: Physicians Office Laboratories (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 34: Reference Laboratories (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 35: Reference Laboratories (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2012-2019
    • TABLE 36: Reference Laboratories (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Tuberculosis Testing Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 37: United States Tuberculosis Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 38: Tuberculosis Testing Market in the United States by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 39: United States Tuberculosis Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 40: United States Tuberculosis Testing Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
    • TABLE 41: Tuberculosis Testing Historic Demand Patterns in the United States by End-Use in US$ Million for 2012-2019
    • TABLE 42: Tuberculosis Testing Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 43: Canadian Tuberculosis Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 44: Canadian Tuberculosis Testing Historic Market Review by Test Type in US$ Million: 2012-2019
    • TABLE 45: Tuberculosis Testing Market in Canada: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027
    • TABLE 46: Canadian Tuberculosis Testing Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 47: Tuberculosis Testing Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 48: Canadian Tuberculosis Testing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • JAPAN
    • TABLE 49: Japanese Market for Tuberculosis Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 50: Tuberculosis Testing Market in Japan: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 51: Japanese Tuberculosis Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
    • TABLE 52: Japanese Demand Estimates and Forecasts for Tuberculosis Testing in US$ Million by End-Use: 2020 to 2027
    • TABLE 53: Japanese Tuberculosis Testing Market in US$ Million by End-Use: 2012-2019
    • TABLE 54: Tuberculosis Testing Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 55: Chinese Tuberculosis Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 56: Tuberculosis Testing Historic Market Analysis in China in US$ Million by Test Type: 2012-2019
    • TABLE 57: Chinese Tuberculosis Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 58: Chinese Demand for Tuberculosis Testing in US$ Million by End-Use: 2020 to 2027
    • TABLE 59: Tuberculosis Testing Market Review in China in US$ Million by End-Use: 2012-2019
    • TABLE 60: Chinese Tuberculosis Testing Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European Tuberculosis Testing Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 61: European Tuberculosis Testing Market Demand Scenario in US$ Million by Region/Country: 2020-2027
    • TABLE 62: Tuberculosis Testing Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 63: European Tuberculosis Testing Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 64: European Tuberculosis Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 65: Tuberculosis Testing Market in Europe in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 66: European Tuberculosis Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 67: European Tuberculosis Testing Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 68: Tuberculosis Testing Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 69: European Tuberculosis Testing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 70: Tuberculosis Testing Market in France by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 71: French Tuberculosis Testing Historic Market Scenario in US$ Million by Test Type: 2012-2019
    • TABLE 72: French Tuberculosis Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
    • TABLE 73: Tuberculosis Testing Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027
    • TABLE 74: French Tuberculosis Testing Historic Market Review in US$ Million by End-Use: 2012-2019
    • TABLE 75: French Tuberculosis Testing Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • GERMANY
    • TABLE 76: Tuberculosis Testing Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 77: German Tuberculosis Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 78: German Tuberculosis Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 79: Tuberculosis Testing Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
    • TABLE 80: German Tuberculosis Testing Market in Retrospect in US$ Million by End-Use: 2012-2019
    • TABLE 81: Tuberculosis Testing Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 82: Italian Tuberculosis Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 83: Tuberculosis Testing Historic Market Analysis in Italy in US$ Million by Test Type: 2012-2019
    • TABLE 84: Italian Tuberculosis Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 85: Italian Demand for Tuberculosis Testing in US$ Million by End-Use: 2020 to 2027
    • TABLE 86: Tuberculosis Testing Market Review in Italy in US$ Million by End-Use: 2012-2019
    • TABLE 87: Italian Tuberculosis Testing Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 88: United Kingdom Market for Tuberculosis Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 89: Tuberculosis Testing Market in the United Kingdom: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 90: United Kingdom Tuberculosis Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
    • TABLE 91: United Kingdom Demand Estimates and Forecasts for Tuberculosis Testing in US$ Million by End-Use: 2020 to 2027
    • TABLE 92: United Kingdom Tuberculosis Testing Market in US$ Million by End-Use: 2012-2019
    • TABLE 93: Tuberculosis Testing Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027
  • SPAIN
    • TABLE 94: Spanish Tuberculosis Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 95: Spanish Tuberculosis Testing Historic Market Review by Test Type in US$ Million: 2012-2019
    • TABLE 96: Tuberculosis Testing Market in Spain: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027
    • TABLE 97: Spanish Tuberculosis Testing Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 98: Tuberculosis Testing Market in Spain: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 99: Spanish Tuberculosis Testing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • RUSSIA
    • TABLE 100: Russian Tuberculosis Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 101: Tuberculosis Testing Market in Russia by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 102: Russian Tuberculosis Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 103: Russian Tuberculosis Testing Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
    • TABLE 104: Tuberculosis Testing Historic Demand Patterns in Russia by End-Use in US$ Million for 2012-2019
    • TABLE 105: Tuberculosis Testing Market Share Breakdown in Russia by End-Use: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 106: Rest of Europe Tuberculosis Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 107: Tuberculosis Testing Market in Rest of Europe in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 108: Rest of Europe Tuberculosis Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 109: Rest of Europe Tuberculosis Testing Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 110: Tuberculosis Testing Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 111: Rest of Europe Tuberculosis Testing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 112: Asia-Pacific Tuberculosis Testing Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 113: Tuberculosis Testing Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 114: Asia-Pacific Tuberculosis Testing Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 115: Tuberculosis Testing Market in Asia-Pacific by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 116: Asia-Pacific Tuberculosis Testing Historic Market Scenario in US$ Million by Test Type: 2012-2019
    • TABLE 117: Asia-Pacific Tuberculosis Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
    • TABLE 118: Tuberculosis Testing Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027
    • TABLE 119: Asia-Pacific Tuberculosis Testing Historic Market Review in US$ Million by End-Use: 2012-2019
    • TABLE 120: Asia-Pacific Tuberculosis Testing Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • AUSTRALIA
    • TABLE 121: Tuberculosis Testing Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 122: Australian Tuberculosis Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 123: Australian Tuberculosis Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 124: Tuberculosis Testing Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
    • TABLE 125: Australian Tuberculosis Testing Market in Retrospect in US$ Million by End-Use: 2012-2019
    • TABLE 126: Tuberculosis Testing Market Share Distribution in Australia by End-Use: 2012 VS 2020 VS 2027
  • INDIA
    • TABLE 127: Indian Tuberculosis Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 128: Indian Tuberculosis Testing Historic Market Review by Test Type in US$ Million: 2012-2019
    • TABLE 129: Tuberculosis Testing Market in India: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027
    • TABLE 130: Indian Tuberculosis Testing Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 131: Tuberculosis Testing Market in India: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 132: Indian Tuberculosis Testing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • SOUTH KOREA
    • TABLE 133: Tuberculosis Testing Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 134: South Korean Tuberculosis Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 135: Tuberculosis Testing Market Share Distribution in South Korea by Test Type: 2012 VS 2020 VS 2027
    • TABLE 136: Tuberculosis Testing Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2020-2027
    • TABLE 137: South Korean Tuberculosis Testing Historic Market Analysis in US$ Million by End-Use: 2012-2019
    • TABLE 138: Tuberculosis Testing Market Share Distribution in South Korea by End-Use: 2012 VS 2020 VS 2027
  • REST OF ASIA-PACIFIC
    • TABLE 139: Rest of Asia-Pacific Market for Tuberculosis Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 140: Tuberculosis Testing Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 141: Rest of Asia-Pacific Tuberculosis Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
    • TABLE 142: Rest of Asia-Pacific Demand Estimates and Forecasts for Tuberculosis Testing in US$ Million by End-Use: 2020 to 2027
    • TABLE 143: Rest of Asia-Pacific Tuberculosis Testing Market in US$ Million by End-Use: 2012-2019
    • TABLE 144: Tuberculosis Testing Market Share Shift in Rest of Asia-Pacific by End-Use: 2012 VS 2020 VS 2027
  • LATIN AMERICA
    • TABLE 145: Latin American Tuberculosis Testing Market Trends by Region/Country in US$ Million: 2020-2027
    • TABLE 146: Tuberculosis Testing Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
    • TABLE 147: Latin American Tuberculosis Testing Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
    • TABLE 148: Latin American Tuberculosis Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 149: Tuberculosis Testing Historic Market Analysis in Latin America in US$ Million by Test Type: 2012-2019
    • TABLE 150: Latin American Tuberculosis Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 151: Latin American Demand for Tuberculosis Testing in US$ Million by End-Use: 2020 to 2027
    • TABLE 152: Tuberculosis Testing Market Review in Latin America in US$ Million by End-Use: 2012-2019
    • TABLE 153: Latin American Tuberculosis Testing Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • ARGENTINA
    • TABLE 154: Argentinean Tuberculosis Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 155: Tuberculosis Testing Market in Argentina in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 156: Argentinean Tuberculosis Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 157: Argentinean Tuberculosis Testing Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 158: Tuberculosis Testing Market in Argentina: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 159: Argentinean Tuberculosis Testing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • BRAZIL
    • TABLE 160: Tuberculosis Testing Market in Brazil by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 161: Brazilian Tuberculosis Testing Historic Market Scenario in US$ Million by Test Type: 2012-2019
    • TABLE 162: Brazilian Tuberculosis Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
    • TABLE 163: Tuberculosis Testing Quantitative Demand Analysis in Brazil in US$ Million by End-Use: 2020-2027
    • TABLE 164: Brazilian Tuberculosis Testing Historic Market Review in US$ Million by End-Use: 2012-2019
    • TABLE 165: Brazilian Tuberculosis Testing Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • MEXICO
    • TABLE 166: Tuberculosis Testing Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 167: Mexican Tuberculosis Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 168: Mexican Tuberculosis Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 169: Tuberculosis Testing Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
    • TABLE 170: Mexican Tuberculosis Testing Market in Retrospect in US$ Million by End-Use: 2012-2019
    • TABLE 171: Tuberculosis Testing Market Share Distribution in Mexico by End-Use: 2012 VS 2020 VS 2027
  • REST OF LATIN AMERICA
    • TABLE 172: Rest of Latin America Tuberculosis Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 173: Tuberculosis Testing Market in Rest of Latin America by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 174: Rest of Latin America Tuberculosis Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 175: Rest of Latin America Tuberculosis Testing Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
    • TABLE 176: Tuberculosis Testing Historic Demand Patterns in Rest of Latin America by End-Use in US$ Million for 2012-2019
    • TABLE 177: Tuberculosis Testing Market Share Breakdown in Rest of Latin America by End-Use: 2012 VS 2020 VS 2027
  • MIDDLE EAST
    • TABLE 178: The Middle East Tuberculosis Testing Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 179: Tuberculosis Testing Market in the Middle East by Region/Country in US$ Million: 2012-2019
    • TABLE 180: The Middle East Tuberculosis Testing Market Share Breakdown by Region/Country: 2012, 2020, and 2027
    • TABLE 181: The Middle East Tuberculosis Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 182: The Middle East Tuberculosis Testing Historic Market by Test Type in US$ Million: 2012-2019
    • TABLE 183: Tuberculosis Testing Market in the Middle East: Percentage Share Breakdown of Sales by Test Type for 2012,2020, and 2027
    • TABLE 184: The Middle East Tuberculosis Testing Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 185: Tuberculosis Testing Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 186: The Middle East Tuberculosis Testing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • IRAN
    • TABLE 187: Iranian Market for Tuberculosis Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 188: Tuberculosis Testing Market in Iran: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 189: Iranian Tuberculosis Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
    • TABLE 190: Iranian Demand Estimates and Forecasts for Tuberculosis Testing in US$ Million by End-Use: 2020 to 2027
    • TABLE 191: Iranian Tuberculosis Testing Market in US$ Million by End-Use: 2012-2019
    • TABLE 192: Tuberculosis Testing Market Share Shift in Iran by End-Use: 2012 VS 2020 VS 2027
  • ISRAEL
    • TABLE 193: Israeli Tuberculosis Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 194: Tuberculosis Testing Market in Israel in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 195: Israeli Tuberculosis Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 196: Israeli Tuberculosis Testing Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 197: Tuberculosis Testing Market in Israel: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 198: Israeli Tuberculosis Testing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • SAUDI ARABIA
    • TABLE 199: Saudi Arabian Tuberculosis Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 200: Tuberculosis Testing Historic Market Analysis in Saudi Arabia in US$ Million by Test Type: 2012-2019
    • TABLE 201: Saudi Arabian Tuberculosis Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 202: Saudi Arabian Demand for Tuberculosis Testing in US$ Million by End-Use: 2020 to 2027
    • TABLE 203: Tuberculosis Testing Market Review in Saudi Arabia in US$ Million by End-Use: 2012-2019
    • TABLE 204: Saudi Arabian Tuberculosis Testing Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • UNITED ARAB EMIRATES
    • TABLE 205: Tuberculosis Testing Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 206: United Arab Emirates Tuberculosis Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 207: Tuberculosis Testing Market Share Distribution in United Arab Emirates by Test Type: 2012 VS 2020 VS 2027
    • TABLE 208: Tuberculosis Testing Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2020-2027
    • TABLE 209: United Arab Emirates Tuberculosis Testing Historic Market Analysis in US$ Million by End-Use: 2012-2019
    • TABLE 210: Tuberculosis Testing Market Share Distribution in United Arab Emirates by End-Use: 2012 VS 2020 VS 2027
  • REST OF MIDDLE EAST
    • TABLE 211: Tuberculosis Testing Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 212: Rest of Middle East Tuberculosis Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 213: Rest of Middle East Tuberculosis Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 214: Tuberculosis Testing Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
    • TABLE 215: Rest of Middle East Tuberculosis Testing Market in Retrospect in US$ Million by End-Use: 2012-2019
    • TABLE 216: Tuberculosis Testing Market Share Distribution in Rest of Middle East by End-Use: 2012 VS 2020 VS 2027
  • AFRICA
    • TABLE 217: African Tuberculosis Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 218: Tuberculosis Testing Market in Africa by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 219: African Tuberculosis Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
    • TABLE 220: African Tuberculosis Testing Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
    • TABLE 221: Tuberculosis Testing Historic Demand Patterns in Africa by End-Use in US$ Million for 2012-2019
    • TABLE 222: Tuberculosis Testing Market Share Breakdown in Africa by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 42
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.